Sha, Yongqiang <br/><br/>
MGF E peptide pretreatment improves the proliferation and osteogenic differentiation of BMSCs via MEK-ERK1/2 and PI3K-Akt pathway under severe hypoxia.  [electronic resource] 

 -  Life sciences  Nov 2017 
 - 52-62 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1879-0631 
<br/><br/><label>Standard No.: </label>10.1016/j.lfs.2017.09.017  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Blotting, Western<br/>Cell Differentiation--drug effects<br/>Cell Proliferation--drug effects<br/>Female<br/>Flow Cytometry<br/>Fluorescent Antibody Technique<br/>Hypoxia--physiopathology<br/>Hypoxia-Inducible Factor 1, alpha Subunit--metabolism<br/>Insulin-Like Growth Factor I--pharmacology<br/>MAP Kinase Signaling System--drug effects<br/>Mesenchymal Stem Cells--cytology<br/>Osteoblasts--cytology<br/>Osteogenesis--drug effects<br/>Phosphatidylinositol 3-Kinase--metabolism<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Rats<br/>Rats, Sprague-Dawley<br/>Real-Time Polymerase Chain Reaction<br/>Time Factors